日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

耐药性持久性癌细胞易受 GPX4 抑制

Matthew J Hangauer, Vasanthi S Viswanathan, Matthew J Ryan, Dhruv Bole, John K Eaton, Alexandre Matov, Jacqueline Galeas, Harshil D Dhruv, Michael E Berens, Stuart L Schreiber, Frank McCormick, Michael T McManus

Nanoparticle Targeting and Cholesterol Flux Through Scavenger Receptor Type B-1 Inhibits Cellular Exosome Uptake

纳米颗粒靶向和胆固醇通过 B-1 型清道夫受体通量抑制细胞外泌体的摄取

Michael P Plebanek, R Kannan Mutharasan, Olga Volpert, Alexandre Matov, Jesse C Gatlin, C Shad Thaxton

ERG induces taxane resistance in castration-resistant prostate cancer

ERG诱导去势抵抗性前列腺癌产生紫杉烷类药物耐药性

Giuseppe Galletti ,Alexandre Matov ,Himisha Beltran ,Jacqueline Fontugne ,Juan Miguel Mosquera ,Cynthia Cheung ,Theresa Y MacDonald ,Matthew Sung ,Sandra O'Toole ,James G Kench ,Sung Suk Chae ,Dragi Kimovski ,Scott T Tagawa ,David M Nanus ,Mark A Rubin ,Lisa G Horvath ,Paraskevi Giannakakou ,David S Rickman

Androgen receptor splice variants determine taxane sensitivity in prostate cancer

雄激素受体剪接变体决定前列腺癌对紫杉烷的敏感性

Maria Thadani-Mulero #, Luigi Portella #, Shihua Sun, Matthew Sung, Alexandre Matov, Robert L Vessella, Eva Corey, David M Nanus, Stephen R Plymate, Paraskevi Giannakakou

NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents

NAD+ 和 SIRT3 控制微管动力学并降低对抗微管药物的敏感性

William T Harkcom, Ananda K Ghosh, Matthew S Sung, Alexandre Matov, Kevin D Brown, Paraskevi Giannakakou, Samie R Jaffrey